Treatment options are another thing we don’t hear about often enough when talking COVID mandates.
This seems like good news:
An inexpensive antidepressant drug has been found to reduce the risk of hospitalization in high-risk adults recently diagnosed with COVID-19 by over 30 percent, according to a study published in The Lancet Global Health.
Shouldn’t it be the case that available treatments factor into decisions about whether public health outweighs individual rights? We certainly acknowledge that as the case for other diseases for which we require vaccines.